Utah Medical Products Total Assets 2006-2019 | UTMD

Utah Medical Products total assets from 2006 to 2019. Total assets can be defined as the sum of all assets on a company's balance sheet.
Utah Medical Products Annual Total Assets
(Millions of US $)
2018 $100
2017 $93
2016 $76
2015 $79
2014 $81
2013 $81
2012 $77
2011 $76
2010 $41
2009 $42
2008 $39
2007 $46
2006 $44
2005 $42
Utah Medical Products Quarterly Total Assets
(Millions of US $)
Q3 2019 $104
Q2 2019 $103
Q1 2019 $105
Q4 2018 $100
Q3 2018 $99
Q2 2018 $97
Q1 2018 $97
Q4 2017 $93
Q3 2017 $91
Q2 2017 $86
Q1 2017 $82
Q4 2016 $76
Q3 2016 $83
Q2 2016 $81
Q1 2016 $83
Q4 2015 $79
Q3 2015 $80
Q2 2015 $80
Q1 2015 $75
Q4 2014 $81
Q3 2014 $82
Q2 2014 $84
Q1 2014 $83
Q4 2013 $81
Q3 2013 $81
Q2 2013 $76
Q1 2013 $76
Q4 2012 $77
Q3 2012 $79
Q2 2012 $77
Q1 2012 $80
Q4 2011 $76
Q3 2011 $79
Q2 2011 $81
Q1 2011 $82
Q4 2010 $41
Q3 2010 $44
Q2 2010 $43
Q1 2010 $44
Q4 2009 $42
Q3 2009 $42
Q2 2009 $40
Q1 2009 $41
Q4 2008 $39
Q3 2008 $46
Q2 2008 $46
Q1 2008 $47
Q4 2007 $46
Q3 2007 $46
Q2 2007 $45
Q1 2007 $46
Q4 2006 $44
Q3 2006 $43
Q2 2006 $42
Q1 2006 $42
Q4 2005 $42
Q3 2005 $37
Q2 2005 $37
Q1 2005 $41
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.385B $0.042B
Utah Medical Products is in the business of producing cost-effective devices for the healthcare industry which are predominantly proprietary, disposable and for hospital use. The company's success in rapidly producing solutions comes from its proven ability to integrate a number of engineering and technical disciplines in electronics, software, mechanical packaging, instrumentation, optics and materials. The resulting proprietary products represent significant incremental improvementsover existing clinical techniques.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $159.868B 27.90
Medtronic (MDT) Ireland $159.853B 22.08
Stryker (SYK) United States $80.144B 26.95
Boston Scientific (BSX) United States $60.227B 28.43
Baxter (BAX) United States $46.348B 28.10
Essilor Luxottica (ESLOY) France $32.970B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.400B 19.07
Lonza Group Ag (LZAGY) Switzerland $30.070B 0.00
Coloplast (CLPBY) Denmark $27.194B 41.97
Terumo (TRUMY) Japan $27.183B 0.00
ResMed (RMD) United States $23.349B 43.07
Smith & Nephew SNATS (SNN) United Kingdom $22.117B 0.00
Sunny Optical Technology (SNPTF) China $19.732B 0.00
Insulet (PODD) United States $11.904B 566.35
Bio-Rad Laboratories (BIO) United States $11.075B 53.16
Perrigo (PRGO) Ireland $7.998B 14.91
Canopy Growth (CGC) Canada $7.913B 0.00
William Demant Holdings (WILYY) Denmark $7.896B 0.00
DiaSorin S.p.A (DSRLF) Italy $7.357B 0.00
Hill-Rom Holdings (HRC) United States $7.341B 21.13
GN STORE NORD (GNNDY) Denmark $6.158B 0.00
Haemonetics (HAE) United States $5.446B 36.80
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
NuVasive (NUVA) United States $4.013B 31.60
ICU Medical (ICUI) United States $3.880B 25.30
Neogen (NEOG) United States $3.553B 59.13
GW Pharmaceuticals (GWPH) United Kingdom $3.537B 0.00
Quidel (QDEL) United States $3.250B 30.84
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.132B 0.00
Agios Pharmaceuticals (AGIO) United States $3.123B 0.00
National Vision Holdings (EYE) United States $2.908B 65.64
Aurora Cannabis (ACB) Canada $2.168B 0.00
Cardiovascular Systems (CSII) United States $1.807B 0.00
InMode (INMD) Israel $1.563B 0.00
AtriCure (ATRC) United States $1.486B 0.00
TG Therapeutics (TGTX) United States $1.344B 0.00
Aphria (APHA) $1.331B 0.00
VAREX IMAGING (VREX) United States $1.175B 23.49
Phibro Animal Health (PAHC) United States $1.024B 19.17
NanoString Technologies (NSTG) United States $1.005B 0.00
PetIQ (PETQ) United States $0.873B 21.30
Eagle Pharmaceuticals (EGRX) United States $0.778B 29.81
Quanterix (QTRX) United States $0.752B 0.00
LeMaitre Vascular (LMAT) United States $0.729B 40.99
Lantheus Holdings (LNTH) United States $0.708B 17.68
Omeros (OMER) United States $0.674B 0.00
Cerus (CERS) United States $0.641B 0.00
Surmodics (SRDX) United States $0.548B 56.80
MacroGenics (MGNX) United States $0.529B 0.00
OraSure Technologies (OSUR) United States $0.490B 29.41
Organigram Holdings (OGI) Canada $0.451B 0.00
Meridian Bioscience (VIVO) United States $0.408B 14.02
HEXO (HEXO) $0.401B 0.00
Owens & Minor (OMI) United States $0.394B 14.58
Zynex (ZYXI) United States $0.331B 37.48
BioLife Solutions (BLFS) United States $0.310B 126.17
Bovie Medical (APYX) United States $0.274B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.256B 0.00
Female Health (VERU) United States $0.243B 0.00
Vapotherm (VAPO) United States $0.241B 0.00
Repro-Med Systems (KRMD) United States $0.233B 0.00
United Health Products (UEEC) United States $0.224B 0.00
Viemed Healthcare (VMD) United States $0.209B 22.00
Liberty Health Sciences (LHSIF) Canada $0.178B 0.00
Rockwell Medical (RMTI) United States $0.164B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.164B 0.00
Cytosorbents (CTSO) United States $0.149B 0.00
Fonar (FONR) United States $0.132B 9.32
Chimerix (CMRX) United States $0.117B 0.00
MTech Acquisition (KERN) United States $0.096B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.090B 0.00
Surface Oncology (SURF) United States $0.086B 0.00
United-Guardian (UG) United States $0.083B 20.95
MRI Interventions (MRIC) United States $0.078B 0.00
Nephros (NEPH) United States $0.077B 0.00
Chembio Diagnostics (CEMI) United States $0.074B 0.00
FSD PHARMA INC (HUGE) $0.049B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Trinity Biotech (TRIB) Ireland $0.030B 0.00
GUARDION HEALTH (GHSI) United States $0.024B 0.00
NF Energy Saving (BIMI) China $0.023B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.014B 0.00
Senestech (SNES) United States $0.010B 0.00
Capricor Therapeutics (CAPR) United States $0.008B 0.00
Valeritas Holdings (VLRX) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.005B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00